Welcome to the official website of Taizhi Medical.
Beyond the Barrier: Ensuring Clinical Continuity with Taizhi Medical’s EN 14683 Type IIR Surgical Masks
Release time:
Mar 18,2026
The recent U.S. probe into imported surgical masks underscores a critical vulnerability in the global medical consumable market: the over-reliance on non-diversified supply chains. As the industry braces for a potential 25% tariff on imported PPE, the focus is shifting toward manufacturers who can guarantee "Surgical Grade" integrity without compromise. Taizhi Medical addresses this need with its premium line of Medical Surgical Masks, specifically engineered to adhere to the EN 14683 Type IIR standard—the highest classification for fluid resistance and bacterial filtration efficiency (BFE ≥ 98%). In a clinical setting, where blood splashes and aerosolized pathogens are constant risks, Taizhi’s medical-grade solutions provide the robust barrier protection required for complex surgical procedures and intensive care environments.
What sets Taizhi Medical apart in this turbulent regulatory climate is our massive investment in quality control. With a registered capital of 110 million RMB, our facility in Qinhuangdao is equipped with a professional-grade laboratory for real-time testing of synthetic blood penetration and pressure differentials. This ensures that every batch of Type IIR masks leaving our facility meets international clinical protocols. As the Section 232 investigation evaluates "domestic manufacturing capacity," Taizhi Medical reinforces the global market by offering a scalable, high-volume production model that supports international healthcare systems, ensuring that front line workers are never left without essential, high-fluid-resistance protection.
- Source Resources:
Industry White Paper (2026): The Impact of Trade Barriers on Global Medical Consumable Pricing.
Taizhi Medical Quality Assurance: Bacterial Filtration Efficiency (BFE) and Breathability Verification Reports.
keywords
Latest Blog


